GE Healthcare of Chalfont St. Giles, U.K., has received U.S. Food and Drug Administration clearance for a new software package for the fusion of PET/CT and SPECT/CT cardiac studies.
The FDA in May cleared CardIQ Fusion, a dedicated cardiac fusion application that enables users to fuse CT, PET, and SPECT heart images on the company's AW Workstation. Clinicians can use the application to review and analyze CT angiography data for stenosis detection, vessel analysis, and quantification. Users can also assess physiological data such as perfusion and viability from PET or SPECT studies in the American Society of Nuclear Cardiology layout.
Images can be generated either on a hybrid PET/CT or SPECT/CT system, or on independent systems on different dates, and can either be viewed as fused or separate images. The application supports the review of either 3D-rendered formats or 2D reformats such as axial, sagittal, coronal, and curvilinear views, according to the company.
CardIQ Fusion was developed in collaboration with University Hospital Zurich in Switzerland, and a SPECT/CT image produced by the application was given Image of the Year honors at the 2006 Society of Nuclear Medicine (SNM) meeting in San Diego.
By AuntMinnie.com staff writers
June 12, 2006
Related Reading
GE investigates Omniscan cases, June 12, 2006
GE launches new SPECT/CT unit at SNM show, June 7, 2006
GE rolls out Vivid 7 software upgrade, June 5, 2006
GE unit to test new agent for cancer detection, June 5, 2006
GE launches Swedish IT project, May 31, 2006
Copyright © 2006 AuntMinnie.com
